EP3752168A4 - Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis - Google Patents
Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis Download PDFInfo
- Publication number
- EP3752168A4 EP3752168A4 EP18906067.6A EP18906067A EP3752168A4 EP 3752168 A4 EP3752168 A4 EP 3752168A4 EP 18906067 A EP18906067 A EP 18906067A EP 3752168 A4 EP3752168 A4 EP 3752168A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- bone mass
- acid chelate
- calcium absorption
- treat osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 239000013522 chelant Substances 0.000 title 1
- -1 ferrous amino acid Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SG2018/050067 WO2019160500A1 (en) | 2018-02-14 | 2018-02-14 | Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3752168A1 EP3752168A1 (en) | 2020-12-23 |
EP3752168A4 true EP3752168A4 (en) | 2021-10-13 |
Family
ID=67618806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18906067.6A Withdrawn EP3752168A4 (en) | 2018-02-14 | 2018-02-14 | Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3752168A4 (en) |
WO (1) | WO2019160500A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040228950A1 (en) * | 2003-05-13 | 2004-11-18 | The Procter & Gamble Company | Cereal grain kernels fortified with iron and calcium |
CN101058782A (en) * | 2006-04-20 | 2007-10-24 | 缪锦来 | Sports beer |
CN101513259B (en) * | 2009-04-03 | 2012-01-25 | 重庆市生物技术研究所有限责任公司 | Calcium supplementing product |
CN102335266B (en) * | 2011-10-22 | 2013-03-27 | 汪甬伟 | Health care product for supplementing calcium |
WO2014159886A1 (en) * | 2013-03-14 | 2014-10-02 | Amip, Llc | Phosphorus-sparing nutritional composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07252156A (en) * | 1994-03-15 | 1995-10-03 | Meiji Seika Kaisha Ltd | Medicine for prevention and therapy of osteoporosis |
US20120114758A1 (en) * | 2010-06-17 | 2012-05-10 | James Elgin Rea | Beverage for pregnancy & lactation |
CN105145846A (en) * | 2015-10-27 | 2015-12-16 | 江西美庐乳业集团有限公司 | Nutritional bag for increasing bone density and improving osteoporosis |
CN107509996A (en) * | 2017-08-30 | 2017-12-26 | 常州市海若纺织品有限公司 | A kind of bone diet nutritional powder and preparation method thereof |
-
2018
- 2018-02-14 WO PCT/SG2018/050067 patent/WO2019160500A1/en unknown
- 2018-02-14 EP EP18906067.6A patent/EP3752168A4/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040228950A1 (en) * | 2003-05-13 | 2004-11-18 | The Procter & Gamble Company | Cereal grain kernels fortified with iron and calcium |
CN101058782A (en) * | 2006-04-20 | 2007-10-24 | 缪锦来 | Sports beer |
CN101513259B (en) * | 2009-04-03 | 2012-01-25 | 重庆市生物技术研究所有限责任公司 | Calcium supplementing product |
CN102335266B (en) * | 2011-10-22 | 2013-03-27 | 汪甬伟 | Health care product for supplementing calcium |
WO2014159886A1 (en) * | 2013-03-14 | 2014-10-02 | Amip, Llc | Phosphorus-sparing nutritional composition |
Non-Patent Citations (1)
Title |
---|
See also references of WO2019160500A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP3752168A1 (en) | 2020-12-23 |
WO2019160500A1 (en) | 2019-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015501868A1 (en) | Inhibitors of histone demethylases | |
PH12017502433B1 (en) | Mixture for treating fertilisers containing urea | |
EP3173092A3 (en) | Rna containing composition for treatment of tumor diseases | |
MX2018010374A (en) | Inhibitors of wdr5 protein-protein binding. | |
EP4282479A3 (en) | Use of pridopidine to treat depression or anxiety | |
PH12016502355A1 (en) | Pharmaceutical composition | |
SG11202112872YA (en) | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | |
WO2016073989A3 (en) | Osteochondroreticular stem cells for bone and cartilage regeneration | |
MX2014005440A (en) | Nadph oxidase 4 inhibitors and use thereof. | |
EP3185905A4 (en) | Compositions and methods for enhancing healing and regeneration of bone and soft tissue | |
TW201625535A (en) | Inhibitors of histone demethylases | |
MX2020002399A (en) | Inhibitors of wdr5 protein-protein binding. | |
EA201890193A1 (en) | COMPOSITION FOR CARE OF THE ORAL CAVITY | |
PH12017500156A1 (en) | Angiopoietin-like 4 antibodies and methods of use | |
WO2015084883A3 (en) | Compositions and methods for treating osteoarthritis | |
EA201792085A1 (en) | MIXED DISULPHIDE CONJUGATES OF THYENOPYRIDINE COMPOUNDS AND THEIR APPLICATION | |
TW201613569A (en) | Composition consisting of kukoamine A and/or kukoamine B and method of using thereof | |
EP3752168A4 (en) | Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis | |
MX2021006488A (en) | Compositions for improving sexual function. | |
PH12019500180A1 (en) | Compositions for the treatment of pulmonary fibrosis | |
GB2530229A (en) | A splint | |
MX2018002075A (en) | Composition comprising tannins. | |
EP3768274A4 (en) | A composition for use in the treatment of conditions caused by calcium deficiency | |
MX2015007460A (en) | Diazepine derivatives useful as calcium channel blockers in the treatment of pain. | |
MX2016017321A (en) | Combinations and methods for the treatment of neuropathic pain. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200911 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210915 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 19/10 20060101ALI20210909BHEP Ipc: A61K 31/295 20060101ALI20210909BHEP Ipc: A61K 31/198 20060101ALI20210909BHEP Ipc: A61K 33/06 20060101ALI20210909BHEP Ipc: A61K 33/26 20060101AFI20210909BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220420 |